Iloprost Una alternativa en la prueba de vasorreactividad pulmonar
Bastidas, Alirio Rodrigo.
Acta méd. colomb
; 41(4): 217-218, oct.-dic. 2016.
Artículo en Español | LILACS, COLNAL | ID: biblio-949518
Documentos relacionados
Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension.
Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective.
Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis.
Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
Inhaled iloprost in off-pump coronary artery bypass surgery: a randomized controlled trial.
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
Efficacy and safety of endotracheal instillation of iloprost for persistent pulmonary hypertension of the newborn.
Inhaled treprostinil vs iloprost: Comparison of adherence, persistence, and health care resource utilization in patients with pulmonary arterial hypertension.
Prueba de vasorreactividad con iloprost en hipertensión arterial pulmonar
FDA Approves Iloprost as First Drug to Treat Severe Frostbite.